ABCG2 and colorectal cancer: To examine whether AZ32 reversed ABCG2-mediated MDR in colorectal cancer cells is due to inhibition of the transporter activity of ABCG2, we detected the intracellular levels of three ABCG2 substrates mitoxantrone, doxorubicin and rhodamine 123 in the presence or absence of AZ32.